These candidate markers (CLDN4, EPCAM, CD151, LGALS3BP, HIST2H2BE, and HIST2H2BF) effectively isolated tumor-derived EVs in clinical samples [28]. This evidence concerns the gene LGALS3BP and neoplasm.